Dr. Awan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661- Is this information wrong?
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
Aga Khan Medical CollegeClass of 2001
Certifications & Licensure
TX State Medical License 2018 - 2025
OH State Medical License 2006 - 2019
GA State Medical License 2009 - 2014
Clinical Trials
- Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia Start of enrollment: 2010 Sep 01
- Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2011 Sep 08
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2016 Jan 12
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.Catherine S Diefenbach, Thomas A Jandl, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Jacob D Soumerai, Deepa Jagadeesh, Adam Asch, Abhij...> ;British Journal of Haematology. 2024 Mar 19
- RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies.Koduru, P., John, S., Garcia, R., Chen, W., Fuda, F., Kaur, G., Awan, F., Gagan, J.> ;Clinical Pathology. 2024 Feb 16
- Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal, Emily Craver, Narendranath Epperla, Zhuo Li, Iris Isufi, Farrukh T Awan, Bhagirathbhai ...> ;Bone Marrow Transplantation. 2024 Feb 1
- Join now to see all
Abstracts/Posters
- Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin LymphomaFarrukh T. Awan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 42-Month Follow-up of a Phase 2 StudyFarrukh T Awan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Final Results of a Phase 2 Trial of Early Intervention Ibrutinib with Vaccinations in Patients with Asymptomatic, High-Risk CLLFarrukh T. Awan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
The IntersectionFebruary 1st, 2022
Lymphoma Research Foundation to Host Nationwide Virtual RallyApril 28th, 2020
Questions with BTK Inhibitors and Anti-CD20 Combos Require Further Study in CLLApril 10th, 2020- Join now to see all
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
William P. Clements, Jr. University HospitalDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
